As of 2026-01-06, the Relative Valuation of Health Catalyst Inc (HCAT) is (45.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.29 USD, the upside of Health Catalyst Inc based on Relative Valuation is -2091.7%.
The range of the Relative Valuation is (40.57) - (47.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 31.0x | 25.0x |
| Forward P/E multiples | 26.7x - 37.8x | 34.9x |
| Fair Price | (40.57) - (47.23) | (45.61) |
| Upside | -1871.4% - -2162.5% | -2091.7% |
| Date | P/E |
| 2026-01-05 | -1.51 |
| 2026-01-02 | -1.50 |
| 2025-12-31 | -1.57 |
| 2025-12-30 | -1.56 |
| 2025-12-29 | -1.66 |
| 2025-12-26 | -1.59 |
| 2025-12-24 | -1.56 |
| 2025-12-23 | -1.54 |
| 2025-12-22 | -1.60 |
| 2025-12-19 | -1.54 |
| 2025-12-18 | -1.56 |
| 2025-12-17 | -1.57 |
| 2025-12-16 | -1.60 |
| 2025-12-15 | -1.54 |
| 2025-12-12 | -1.62 |
| 2025-12-11 | -1.68 |
| 2025-12-10 | -1.74 |
| 2025-12-09 | -1.72 |
| 2025-12-08 | -1.74 |
| 2025-12-05 | -1.71 |
| 2025-12-04 | -1.77 |
| 2025-12-03 | -1.79 |
| 2025-12-02 | -1.81 |
| 2025-12-01 | -1.91 |
| 2025-11-28 | -1.97 |
| 2025-11-26 | -1.92 |
| 2025-11-25 | -1.82 |
| 2025-11-24 | -1.65 |
| 2025-11-21 | -1.55 |
| 2025-11-20 | -1.33 |
| 2025-11-19 | -1.39 |
| 2025-11-18 | -1.43 |
| 2025-11-17 | -1.47 |
| 2025-11-14 | -1.49 |
| 2025-11-13 | -1.54 |
| 2025-11-12 | -1.62 |
| 2025-11-11 | -1.77 |
| 2025-11-10 | -1.87 |
| 2025-11-07 | -1.86 |
| 2025-11-06 | -1.95 |
| 2025-11-05 | -2.00 |
| 2025-11-04 | -1.99 |
| 2025-11-03 | -2.06 |
| 2025-10-31 | -2.12 |
| 2025-10-30 | -2.16 |
| 2025-10-29 | -2.20 |
| 2025-10-28 | -2.22 |
| 2025-10-27 | -2.27 |
| 2025-10-24 | -2.13 |
| 2025-10-23 | -2.01 |